Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Zang

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Surgery (London, England)|December 5, 2025
A commentary on robotic thyroidectomy and surgical equity--letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|December 9, 2025
Refining adjuvant immunotherapy strategy for resectable ESCCA call for exposure definition, MRD integration, and value-based models - letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|December 9, 2025
Frailty and postoperative weakness in thymoma surgery mechanistic endpoints, calibrated indices, and translational gaps - Letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|February 18, 2026
Letter to the editor--Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancerMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|February 24, 2026
Beyond survival: reassessing long-term immunologic risks of thymectomyMan Sun, Dan Zang, Jun Chen
American Journal of Respiratory and Critical Care Medicine|June 9, 2026
Interpreting Benefit in ELEVATE-IPFMan Sun, Dan Zang, Jun Chen
Diabetes, Obesity & Metabolism|May 31, 2026
GLP-1 RA Therapy After Bariatric Surgery: Phenotype, Strategy and SuccessMan Sun, Dan Zang, Jun Chen
Cancer Science|April 9, 2026
When Binding Is Not Blockade: Interpreting IgG4<sup>+</sup> T Cells After PD-1 TherapyMan Sun, Dan Zang, Jun Chen
The American Journal of Clinical Nutrition|February 4, 2026
Beyond prediction: interpreting metabolic signatures of Mediterranean diet in rheumatoid arthritisMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|September 8, 2025
Moving CtDNA From prognosis to practice in esophageal cancer: challenges and opportunities - Letter to the Editor "circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis"Man Sun, Dan Zang, Jun Chen
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Surgery (London, England)|December 5, 2025
A commentary on robotic thyroidectomy and surgical equity--letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|December 9, 2025
Refining adjuvant immunotherapy strategy for resectable ESCCA call for exposure definition, MRD integration, and value-based models - letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|December 9, 2025
Frailty and postoperative weakness in thymoma surgery mechanistic endpoints, calibrated indices, and translational gaps - Letter to the editorMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|February 18, 2026
Letter to the editor--Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancerMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|February 24, 2026
Beyond survival: reassessing long-term immunologic risks of thymectomyMan Sun, Dan Zang, Jun Chen
American Journal of Respiratory and Critical Care Medicine|June 9, 2026
Interpreting Benefit in ELEVATE-IPFMan Sun, Dan Zang, Jun Chen
Diabetes, Obesity & Metabolism|May 31, 2026
GLP-1 RA Therapy After Bariatric Surgery: Phenotype, Strategy and SuccessMan Sun, Dan Zang, Jun Chen
Cancer Science|April 9, 2026
When Binding Is Not Blockade: Interpreting IgG4<sup>+</sup> T Cells After PD-1 TherapyMan Sun, Dan Zang, Jun Chen
The American Journal of Clinical Nutrition|February 4, 2026
Beyond prediction: interpreting metabolic signatures of Mediterranean diet in rheumatoid arthritisMan Sun, Dan Zang, Jun Chen
International Journal of Surgery (London, England)|September 8, 2025
Moving CtDNA From prognosis to practice in esophageal cancer: challenges and opportunities - Letter to the Editor "circulating tumor DNA as a biomarker for progression and survival in esophageal cancer after neoadjuvant therapy and esophagectomy: a systematic review and meta-analysis"Man Sun, Dan Zang, Jun Chen
Pageof 13